Home  |  Important Safety Information  |  Full Prescribing Information PDF
Contact Us  |  Site Map
A
A
A
Print

Adapted from Cady et al. Curr Med Res Opin. 2004;20(9):1465-1472.6

The most common side effects associated with the use of FROVA are dizziness, fatigue, paresthesia, flushing, headache, dry mouth, hot or cold sensation, skeletal pain, chest pain, and dyspepsia.

This was a multicenter, double-blind, placebo-controlled, 2-way crossover study to prospectively evaluate whether FROVA would provide greater relief if given early during a migraine attack. Patients recorded migraine severity at fixed time-points postdose (at 1, 2, 3, 4, and 24 hours).6


NEW! FROVA Formulary Information
Get FROVA formulary status for Commercial, Medicare Part D, and Medicaid managed care plans at EndoFormularyLink.com
+ View references
  1. Kelman L. Pain characteristics of the acute migraine attack. Headache. 2006;46(6):942-953. doi:10.1111/j.1526-4610.2006.00443.x.
  2. Malik SN, Hopkins M, Young WB, Silberstein SD. Acute migraine treatment: patterns of use and satisfaction in a clinical population. Headache. 2006;46(5):773-780. doi:10.1111/j.1526-4610.2006.00437.x.
  3. Headache Classification Subcommittee of the International Headache Society (IHS). The international classification of headache disorders, 2nd edition, 1st revision (ICHD-IIR1). http://ihs-classification.org/_downloads/mixed/ICHD-IIR1final.doc. Updated May 2005. Accessed March 5, 2009.
  4. Guidelines for controlled trials of drugs in migraine. First edition. International Headache Society Committee on Clinical Trials in Migraine. Cephalalgia. 1991;11(1):1-12.
  5. Lipton RB, Stewart WF, Diamond S, Diamond ML, Reed M. Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache. 2001;41(7):646-657.
  6. Cady R, Elkind A, Goldstein J, Keywood C. Randomized, placebo-controlled comparison of early use of frovatriptan in a migraine attack versus dosing after the headache has become moderate to severe. Curr Med Res Opin. 2004;20(9):1465-1472. doi:10.1185/030079904X2745.
  7. Ryan R, Geraud G, Goldstein J, Cady R, Keywood C. Clinical efficacy of frovatriptan: placebo-controlled studies. Headache. 2002;42(suppl 2):S84-S92.
  8. FROVA® [package insert]. Chadds Ford, PA: Endo Pharmaceuticals, Inc; 2007.
  9. Physicians' Desk Reference. 63rd ed. Montvale, NJ: Physicians' Desk Reference Inc; 2008.
  10. RELPAX® [package insert]. New York, NY: Pfizer Inc. Available online at: https://www.pfizerpro.com/product_info/relpax_pi_clinical_pharmacology.jsp. Accessed January 8, 2009.
     

    Important Safety Information

    For more information, please see Full Prescribing Information for FROVA at http://www.frova.com/pi.